Influence of Oral Doxycycline Therapy on the Diversity and Antibiotic Susceptibility of Human Intestinal Bifidobacterial Population
Overview
Authors
Affiliations
Aim: To evaluate the influence of doxycycline therapy on the composition and antibiotic susceptibility of intestinal bifidobacteria.
Methods And Results: Faecal samples were collected from nine subjects receiving doxycycline therapy and ten control subjects, and analysed for bifidobacteria by culturing and PCR-DGGE (denaturing gradient gel electrophoresis). A marked decrease in the diversity (average number of amplicons detected by PCR-DGGE 0.8 in the antibiotic vs 4.3 in the control group) of Bifidobacterium populations was observed during doxycycline therapy. The proportion of a tetracycline-resistant bifidobacterial population was higher in the antibiotic group than in the control group (83%vs 26%). Based on the tet gene PCR, resistance could be associated with the presence of tet(W). In two subjects, strains representing highly similar genetic fingerprints but different tetracycline susceptibilities were detected. A mutation causing lack of functionality in the tet(W) was observed in one of the susceptible strains.
Conclusions: Doxycycline therapy had a drastic effect on the diversity and tetracycline susceptibility of intestinal Bifidobacterium populations.
Significance And Impact Of The Study: The use of broad-spectrum antibiotics increased the pool of tetracycline-resistant commensal bacteria in the intestine. The detection of resistance genes alone is not sufficient for the evaluation of bacterial antibiotic resistance.
Andrei C, Zanfirescu A, Ormeneanu V, Negres S Antibiotics (Basel). 2025; 14(2).
PMID: 40001382 PMC: 11852119. DOI: 10.3390/antibiotics14020138.
Chu V, Glascock A, Donnell D, Grabow C, Brown C, Ward R Nat Med. 2024; 31(1):207-217.
PMID: 39363100 PMC: 11750720. DOI: 10.1038/s41591-024-03274-2.
Langelier C, Chu V, Glascock A, Donnell D, Grabow C, Brown C Res Sq. 2024; .
PMID: 38699315 PMC: 11065088. DOI: 10.21203/rs.3.rs-4243341/v1.
Vanbaelen T, Manoharan-Basil S, Kenyon C Curr Res Microb Sci. 2024; 6:100234.
PMID: 38646593 PMC: 11033152. DOI: 10.1016/j.crmicr.2024.100234.
Bidirectional Interaction between Tetracyclines and Gut Microbiome.
Jaroszewski J, Mamun N, Czaja K Antibiotics (Basel). 2023; 12(9).
PMID: 37760733 PMC: 10525114. DOI: 10.3390/antibiotics12091438.